Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Novartis raises blockbuster drug forecasts to $18 billion as it seeks to prove growth can last

The drugmaker cited strong demand for its blockbuster drugs as it upgraded peak sales forecasts for multiple sclerosis, leukemia, and cholesterol medicines.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Every outlet that reported this, and when →

Read the original at cnbc.com →

More in Finance & Markets

More from Thursday 19 November →